Lv5
1130 积分 2025-08-11 加入
Hepatitis B virus-induced hepatocellular carcinoma: a persistent global problem
1天前
已完结
Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer
20天前
已完结
Tislelizumab in Patients with Previously Treated Advanced Hepatocellular Carcinoma (RATIONALE-208): A Multicenter, Non-Randomized, Open-Label, Phase 2 Trial
23天前
已完结
Preoperative Predictors of Early Recurrence After Liver Resection for Multifocal Hepatocellular Carcinoma
1个月前
已完结
Radical lymph node dissection and assessment: Impact on gallbladder cancer prognosis
1个月前
已完结
A meta-analysis of prognostic factors for early recurrence in perihilar cholangiocarcinoma after curative-intent resection
2个月前
已完结
Prognostic factors for resected cases with gallbladder carcinoma: a systematic review and meta-analysis
2个月前
已完结
[Clinical efficacy and safety analysis of camrelizumab combined with apatinib as a second-line therapy for unresectable hepatocellular carcinoma: a multicenter retrospective study]
2个月前
已完结
Development of a prognostic score for recommended TACE candidates with hepatocellular carcinoma: A multicentre observational study
2个月前
已完结
Gemcitabine and Oxaliplatin Chemotherapy or Surveillance in Resected Biliary Tract Cancer (PRODIGE 12-ACCORD 18-UNICANCER GI): A Randomized Phase III Study
3个月前
已完结
皖公网安备34019202002308
